EBITDA Margin ratio Analysis of Acasti Pharma Inc - Deep Dive
WARN : Please note that some of the values may not be in base currency

Latest FY EBITDA Margin
Period Ending - Mar-23

0


Poor EBITDA Margin
Period Ending - Mar-22
-153761.54

Very Poor EBITDA Margin
Growth
0 %
Trailing Twelve Months EBITDA Margin
Period Ending - Mar-23

58203.12


Excellent EBITDA Margin
Most recent Quarter EBITDA Margin
Period Ending - Dec-23

0


Poor EBITDA Margin
EBITDA Margin Analysis of Acasti Pharma Inc
Ebitda Margin Ratio of Acasti Pharma Inc with value of 58203.12 means that its operating expenses are lower in relation to total revenue in trailing twelve months.
EBITDA Margin Ratio of ACST has grown by 0 % Compared to previous Financial Year.
EBITDA Margin Ratio with value of 0 was highest in Year Mar-23 in last Five Years.
EBITDA Margin Ratio with value of -153761.54 was lowest in Year Mar-22 in last Five Years.
Latest EBITDA Margin Ratio with value of 0 is Greater than Average EBITDA Margin of -31767.51 in last five years.
Other EBITDA Margin Related Info of ACST that may interest you.
Acasti Pharma Inc Overview
CodePricePrevious PricePrice ChangeSector
ACST2.692.7599 2.53 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of EBITDA Margin
EBITDA Margin is the profitability ratio that measures a company's earnings before interest, taxes, depreciation, and amortization as a percentage of revenue. EBITDA is the abbreviation for Earnings before Interest, Taxes, Depreciation, and Amortization.   more ..
EBITDA Margin Formula
EBITDA Margin Related Ratios
NetProfitMarginReturnOnEquity
Tsr Profitability Index
Poor Profitability Stock
FY - Historical EBITDA Margin of Acasti Pharma Inc
PeriodMar-23Mar-22Mar-21Mar-20Mar-19Mar-18Mar-17
EBITDA Margin0-153761.54-5076.020000
Change0 %-2929.17 %0 %
You are view first 7 Records. Log in to view all 14 in Premium view
FY Chart of EBITDA Margin of Acasti Pharma Inc


Note : All Data Generated at the End of Trading Hours (EOD Data)